These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24269421)

  • 1. A combination of topical and systemic carbonic anhydrase in the treatment of chromosome X-linked retinoschisis.
    Rocha Cabrera P; Pareja Ríos AC; Cordovés Dorta L; Mantolán Sarmiento C; Serrano García MA
    Arch Soc Esp Oftalmol; 2014 Aug; 89(8):320-3. PubMed ID: 24269421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis.
    Genead MA; Fishman GA; Walia S
    Arch Ophthalmol; 2010 Feb; 128(2):190-7. PubMed ID: 20142541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USE OF A CARBONIC ANHYDRASE INHIBITOR IN X-LINKED RETINOSCHISIS: Effect on Cystic-Appearing Macular Lesions and Visual Acuity.
    Andreuzzi P; Fishman GA; Anderson RJ
    Retina; 2017 Aug; 37(8):1555-1561. PubMed ID: 27828908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.
    Grover S; Fishman GA; Fiscella RG; Adelman AE
    Retina; 1997; 17(3):222-31. PubMed ID: 9196934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical Anatomic Response to Topical Carbonic Anhydrase Inhibitor in X-linked Retinoschisis.
    Menke B; Walters A; Payne JF
    Ophthalmic Surg Lasers Imaging Retina; 2018 Feb; 49(2):142-144. PubMed ID: 29443366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STELLATE NONHEREDITARY IDIOPATHIC FOVEOMACULAR RETINOSCHISIS: RESPONSE TO TOPICAL DORZOLAMIDE THERAPY.
    Ajlan RS; Hammamji KS
    Retin Cases Brief Rep; 2019; 13(4):364-366. PubMed ID: 28557864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-linked juvenile retinoschisis in females and response to carbonic anhydrase inhibitors: case report and review of the literature.
    Ali S; Seth R
    Semin Ophthalmol; 2013 Jan; 28(1):50-4. PubMed ID: 23163265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of dorzolamide for patients with X-linked retinoschisis.
    Apushkin MA; Fishman GA
    Retina; 2006 Sep; 26(7):741-5. PubMed ID: 16963845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of topical dorzolamide for patients with X-linked juvenile retinoschisis: case report.
    Bastos AL; Freitas Bde P; Villas Boas O; Ramiro AC
    Arq Bras Oftalmol; 2008; 71(2):286-90. PubMed ID: 18516436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dramatic regression of macular and peripheral retinoschisis with dorzolamide 2 % in X-linked retinoschisis: a case report.
    Sadaka A; Sisk RA
    J Med Case Rep; 2016 Jun; 10(1):142. PubMed ID: 27246168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetazolamide in the treatment of X-linked retinoschisis maculopathy.
    Ghajarnia M; Gorin MB
    Arch Ophthalmol; 2007 Apr; 125(4):571-3. PubMed ID: 17420384
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid Collections and Visual Acuity in Patients with X-Linked Retinoschisis.
    Hensman J; Hahn LC; van Schooneveld MJ; Diederen RMH; Ten Brink JB; Florijn RJ; Bergen AA; Strubbe I; Heutinck P; van Genderen MM; van den Born LI; Thiadens AA; de Zaeytijd J; Leroy BP; Hoyng CB; Boon CJF
    Ophthalmol Retina; 2024 Jun; 8(6):600-606. PubMed ID: 38104928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide.
    Iannaccone A; Fung KH; Eyestone ME; Stone EM
    Am J Ophthalmol; 2009 Feb; 147(2):307-312.e2. PubMed ID: 18835469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors in patients with X-linked retinoschisis: effects on macular morphology and function.
    Testa F; Di Iorio V; Gallo B; Marchese M; Nesti A; De Rosa G; Melillo P; Simonelli F
    Ophthalmic Genet; 2019 Jun; 40(3):207-212. PubMed ID: 31149861
    [No Abstract]   [Full Text] [Related]  

  • 15. STRUCTURAL AND FUNCTIONAL MONITORING OF EXTRAMACULAR CYSTOID SPACES IN A CASE OF X-LINKED RETINOSCHISIS TREATED WITH ACETAZOLAMIDE.
    Collison FT; Fishman GA
    Retin Cases Brief Rep; 2018 Fall; 12(4):318-321. PubMed ID: 27984356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of response to treatment with dorzolamide in X-linked retinoschisis to the mechanism of functional loss in retinoschisin.
    Walia S; Fishman GA; Molday RS; Dyka FM; Kumar NM; Ehlinger MA; Stone EM
    Am J Ophthalmol; 2009 Jan; 147(1):111-115.e1. PubMed ID: 18834580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa.
    Liew G; Moore AT; Webster AR; Michaelides M
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1531-6. PubMed ID: 25670491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of mid-peripheral schisis in x-linked retinoschisis with the use of dorzolamide.
    Collison FT; Genead MA; Fishman GA; Stone EM
    Ophthalmic Genet; 2014 Jun; 35(2):125-7. PubMed ID: 23514609
    [No Abstract]   [Full Text] [Related]  

  • 19. X-linked retinoschisis maculopathy treated with topical dorzolamide, and relationship to genotype.
    Khandhadia S; Trump D; Menon G; Lotery AJ
    Eye (Lond); 2011 Jul; 25(7):922-8. PubMed ID: 21527955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification. 1999; 43 (5): 344-6.
    Chakraborty P; Villada JR; Tinu AT
    J R Coll Surg Edinb; 1999 Dec; 44(6):411-2. PubMed ID: 10612969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.